Atrial Fibrillation Clinical Trials in Dallas, Texas

6 studies are recruiting for atrial fibrillation in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. The Fourth Left Atrial Appendage Occlusion Study

   LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Baylor Research Institute, Dallas, Texas

   Locations

   150 in total

   Run by

   Hamilton Health Sciences Corporation

   See if you can join NCT05963698 on ClinicalTrials.gov

2. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

   REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in parti…

   Stage

   Phase 3

   Ages

   22 to 85

   Site

   University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   93 in total

   Run by

   Johns Hopkins University

   See if you can join NCT05836987 on ClinicalTrials.gov

3. PULSED AF Post-Approval Study

   PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Texas Health Research & Education Institute, Dallas, Texas

   Locations

   23 in total

   Run by

   Medtronic Cardiac Ablation Solutions

   See if you can join NCT06578104 on ClinicalTrials.gov

4. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

   Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   UT Southwestern Medical Center, Dallas, Texas

   Locations

   187 in total

   Run by

   Yale University

   See if you can join NCT03907046 on ClinicalTrials.gov

5. Get With the Guidelines Atrial Fibrillation Registry

   Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for conti…

   Stage

   Not phased

   Ages

   18 to 125

   Site

   Amy Bennett, Dallas, Texas

   Run by

   American Heart Association

   See if you can join NCT06245187 on ClinicalTrials.gov

6. Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

   This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

   Stage

   Not phased

   Ages

   20 to 90

   Site

   UT Southwestern Medical Center, Dallas, Texas

   Locations

   3 in total

   Run by

   Brigham and Women's Hospital

   See if you can join NCT01258231 on ClinicalTrials.gov